HIV-1

Fogarty International CenterUS$548.4kNational Institute on AgingUS$829.9kNational Institute of Allergy and Infectious DiseasesUS$1.1m

• "Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"

  Fogarty International CenterMuhimbili University/ Allied Hlth ScisUS$99.3k2019–2024

• Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1

  National Institute on AgingWeill Medical Coll of Cornell UnivUS$214.5k2021–2024

• Impact of HIV-1 and Aging on Mucosal Vaccine Responses

  Veterans AffairsVA Eastern Colorado Health Care System2017–2020

• Tyrosine kinase inhibition to block HIV-1 persistence: a pilot study

  National Institute of Allergy and Infectious DiseasesUniversity of UtahUS$228.8k2020–2023

• In vivo modelling of therapeutic strategies for prevention of HIV-related fibrosis and fatty liver disease in chronic treated HIV-1 infection

  National Institute of Allergy and Infectious DiseasesUniversity of California Los AngelesUS$195k2018–2022

• HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction

  National Heart, Lung, and Blood InstituteUniversity of ColoradoUS$726.3k2016–2020

• Humanized mice as a model to study novel therapies for HIV-Associated Neurocognitive Disorders (HAND) in elderly HIV-1 infected individuals

  National Institute on AgingUniversity of California Los AngelesUS$78k2017–2019

• Lineage marking in humanized mice to reveal HIV-1 reservoirs

  National Institute of Allergy and Infectious DiseasesIcahn School of Medicine at Mount SinaiUS$490.2k2016–2020

• Multidisciplinary Evaluation of Accelerated Aging in HIV-1 Infection

  National Institute on AgingUniversity of Alabama at BirminghamUS$185.6k2017–2020